EIDX
Eidos Therapeutics Inc
Clinical-stage biopharmaceutical company focused on transthyretin amyloidosis treatments
CUSIP: 28249H104HealthcareUS1 holder
Eidos Therapeutics Inc
Clinical-stage biopharmaceutical company focused on transthyretin amyloidosis treatments
No financial data available for this security.